Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin and Ezetimibe in Stable Angina Pectoris and Diabetes Mellitus
NCT03771053Unknown
- Sponsor
- Chinese PLA General Hospital
- Start
- Jan 2018
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of ezetimibe in coronary artery disease (CAD) and hypercholesterolemia (2 arms), sponsored by Chinese PLA General Hospital. Primary endpoint: Plaque Area Volume percentage at 12 months. Status: unknown.
02
Drugs
ezetimibe
03
Conditions
coronary artery disease (CAD)hypercholesterolemia
Beyond the preview
Go deeper on NCT03771053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03771053.